Aerpio Pharmaceuticals Inc

Aadi Bioscience, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancers patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. The company was founded by Neil Desai on November 2007 and is headquartered in Los Angeles, CA.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Aadi Bioscience, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. The company was founded by Neil Desai in November 2007 and is headquartered in Los Angeles, CA.

Ambev

Phunware Inc

Why investors are watching these penny stocks right now The post Top Penny Stocks to Buy? Here's 3 That Investors Are Watching appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Top Penny Stocks to Buy? Here's 3 That Investors Are Watching

Inuvo

Micronet Enertec Technologies

MannKind

RLX Technology

Looking for penny stocks to buy now? The post Best Penny Stocks To Buy Right Now?

Best Penny Stocks To Buy Right Now? 5 To Watch Before September

CINCINNATI, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. (“Aerpio”) (Nasdaq: ARPO), a biopharmaceutical company, today reported financial results for the three and six months ended June 30, 2021 and provided a business update.

Aerpio Reports Second Quarter 2021 Financial Results and Provides Business Update

ConforMIS

Ault Global Holdings

Looking For the Best Penny Stocks to Watch in July? Check These 4 Out The post Penny Stocks to Buy Right Now?

Penny Stocks to Buy Right Now? 4 For Your Late July Watchlist

Advaxis

Ashford Hospitality Trust

Globalstar

Sonim Technologies Inc

Reopening penny stocks are showing momentum right now; here's 6 to watch The post Hot Penny Stocks to Buy Now? 6 Reopening Stocks To Watch In July 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Hot Penny Stocks to Buy Now? 6 Reopening Stocks To Watch In July 2021

Acasti Pharma

Cellect Biotechnology Ltd

Check-Cap

Seelos Therapeutics

SCWorx Corp

Biotech penny stocks are in focus; here's 4 to watch right now The post Best Biotech Penny Stocks to Buy in July 2021? 6 For Your Watchlist appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Best Biotech Penny Stocks to Buy in July 2021? 6 For Your Watchlist

Chiasma

Net Element

1Life Healthcare

Soliton

Sykes Enterprises

NEW YORK , July 10, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: 1Life Healthcare, Inc. (NASDAQ: ONEM)  concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Iora Health. Under the terms of the merger, 1Life Healthcare will acquire Iora Health in an all-stock transaction.

INVESTIGATION ALERT: Halper Sadeh LLP Investigates ONEM, SYKE, NETE, CHMA, SOLY, ARPO; Shareholders are Encouraged to Contact the Firm

Shares of microcap biopharma Aerpio Pharmaceuticals, Inc. (ARPO) are advancing strongly Thursday on above-average volume. The upside in reaction a positive analyst action.

Why Aerpio Shares Are Skyrocketing Today

Aerpio Pharmaceuticals (ARPO) stock is flying high on Thursday after an analyst upgrade gave the company's shares a boost today. The post ARPO Stock: 12 Things to Know About Aerpio Pharma as Analyst Upgrade Sends Shares Soaring appeared first on InvestorPlace.

ARPO Stock: 12 Things to Know About Aerpio Pharma as Analyst Upgrade Sends Shares Soaring

Arbutus Biopharma

Corbus Pharmaceuticals Holdings

Digital Brands Group Inc

9F Inc - ADR

NovaBay Pharmaceuticals

NexGen Energy

Why investors are watching these 7 penny stocks right now The post Which Penny Stocks Are Investors Buying Right Now? 7 For Your Watchlist appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Which Penny Stocks Are Investors Buying Right Now? 7 For Your Watchlist

The stock price of Aerpio Pharmaceuticals Inc (NASDAQ: ARPO) increased by over 45% pre-market. This is why it happened.

Aerpio Pharmaceuticals Stock Increases Over 45% Pre-Market: Why It Happened

CINCINNATI, June 04, 2021 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. (“Aerpio”) (Nasdaq: ARPO) announced that Aadi Bioscience, Inc. (“Aadi”), a privately-held biopharmaceutical company focusing on precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, today issued a press release disclosing that a poster has been presented at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting. As previously disclosed, on May 16, 2021, Aerpio entered into an Agreement and Plan of Merger among Aerpio, Aadi, and Aspen Merger Subsidiary, Inc.

Aerpio Provides Second Update on Aadi Bioscience Presentation at the ASCO 2021 Virtual Meeting

NEW YORK, May 21, 2021 /PRNewswire/ --  Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating Aerpio Pharmaceuticals, Inc. ("ARPO" or the "Company") (ARPO) relating to its proposed merger with Aadi Bioscience, Inc. Under the terms of the agreement, ARPO shareholders are expected to own 14.7% of the combined company after the closing of the concurrent PIPE financing transaction. The investigation focuses on whether Aerpio Pharmaceuticals, Inc. and its Board of Directors violated securities laws and/or breached their fiduciary duties to the Company by 1) failing to conduct a fair process, and 2) whether the transaction is properly valued.

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Aerpio Pharmaceuticals, Inc. - ARPO

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Aerpio Pharmaceuticals, Inc. (“the Company”) (NasdaqGS: ARPO) with Aadi Bioscience, Inc. pursuant to which Aerpio shareholders will own approximately 14.7% of the combined company following the closing of the concurrent PIPE financing. KSF is seeking to determine whether the merger and the process that led t

AERPIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Aerpio Pharmaceuticals, Inc. - ARPO

CINCINNATI, May 19, 2021 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. (“Aerpio”) (Nasdaq: ARPO) announced that Aadi Bioscience (“Aadi”), a privately-held biopharmaceutical company focusing on precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, today issued a press release disclosing its abstract to be presented at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting. As previously disclosed, on May 16, 2021, Aerpio entered into an Agreement and Plan of Merger among Aerpio, Aadi, and Aspen Merger Subsidiary, Inc.

Aerpio Provides Update on Aadi Bioscience Presentation at the ASCO 2021 Virtual Meeting

NEW YORK, May 19, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Aerpio Pharmaceuticals, Inc. ("Aerpio" or the "Company") (NASDAQ: ARPO) in connection with the proposed merger of the Company with privately-held Aadi Bioscience, Inc. ("Aadi"). Under the terms of the merger agreement, the two companies will combine their businesses in an all-stock transaction that will result in one combined entity that will trade publicly on the NASDAQ.

SHAREHOLDER ALERT: WeissLaw LLP Investigates Aerpio Pharmaceuticals, Inc.

Atossa Genetics

Ideanomics Inc

Northwest Biotherapeutics, Inc.

China Xiangtai Food Co Ltd

Senseonics Holdings

Looking for 7 penny stocks that could be buy the dip candidates? Check these out The post 7 Penny Stocks to Watch With Crypto News Sparking a Market Dip appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

7 Penny Stocks to Watch With Crypto News Sparking a Market Dip

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger of Aerpio Pharmaceuticals, Inc. (NASDAQ: ARPO) and Aadi Bioscience, Inc. is fair to Aerpio shareholders. Under the merger, Aadi shareholders will receive newly issued shares of Aerpio common stock. On a pro forma basis, Aerpio shareholders will own approximately 33.2% of the combined company upon the closing of the merger prior to the additional PIPE financing transaction. Followi

Aerpio Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Aerpio Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – ARPO

The stock price of Aerpio Pharmaceuticals Inc (NASDAQ: ARPO) increased by over 55% during intraday trading. This is why it happened.

Aerpio Pharmaceuticals (ARPO) Stock: Over 55% Increase Explanation

Aerpio Pharmaceuticals Inc (NASDAQ: ARPO) has agreed to merge with a privately-held Aadi Bioscience. Following the proposed merger, the new entity will operate under the Aadi Bioscience moniker and focus on advancing Aadi's lead product candidate, Fyarrotm (sirolimus albumin-bound nanoparticles for injectable suspension; nab-sirolimus; ABI-009).

Aerpio Pharmaceuticals Announces Reverse Merger Agreement With Aadi Bioscience

Onconova Therapeutics

These penny stocks moved big in early morning trading; here's why The post Penny Stocks to Buy in May 2021? Here's 3 Big Pre-Market Gainers appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Penny Stocks to Buy in May 2021? Here's 3 Big Pre-Market Gainers

CINCINNATI, May 17, 2021 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. (“Aerpio”) (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2, today reported financial results for the first quarter ended March 31, 2021 and provided a business update.

Aerpio Reports First Quarter 2021 Financial Results and Provides Business Update

CINCINNATI and PACIFIC PALISADES, Calif., May 17, 2021 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. (“Aerpio”) (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2, and Aadi Bioscience, Inc. (“Aadi”), a privately-held biopharmaceutical company focusing on precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, announced their entry into a definitive merger agreement. Following the proposed merger, Aerpio will change its name to “Aadi Bioscience, Inc.” and the combined public company will focus on advancing Aadi's lead product candidate, FYARROTM (sirolimus albumin-bound nanoparticles for injectable suspension; nab-sirolimus; ABI-009).

Aerpio Pharmaceuticals and Aadi Bioscience Enter into a Definitive Merger Agreement

Aerpio Pharmaceuticals (ARPO) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock

Aerpio Pharmaceuticals (ARPO) Is in Oversold Territory: What's Next?

Aerpio Pharmaceuticals, Inc. (ARPO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

News for Aerpio Pharmaceuticals Inc Stock (ARPO)